<DOC>
	<DOCNO>NCT01509833</DOCNO>
	<brief_summary>This study prospective , randomize , parallel , control trial ass efficacy late follicular phase administration low dose hCG oocyte maturity ovarian stimulation 73 poor respond patient undergoing intracytoplasmic sperm injection ( ICSI ) treatment .</brief_summary>
	<brief_title>Efficacy Low Dose hCG Oocyte Maturity Poor Responder Women Undergoing Intracytoplasmic Sperm Injection</brief_title>
	<detailed_description>In study eligible patient randomly allocate three study group permute block randomization method : group A ( control group ) receive recombinant FSH , group B receive rFSH supplement 100IU hCG late follicular phase . Group C receive rFSH supplement 200IU hCG late follicular phase . All patient underwent standard long protocol receive GnRH-a ( Suprefact ) , 0.5cc subcutaneous , start day 17 precede cycle ovulation induction start 14 day thereafter . Patients categorize accord follow stimulation protocol : Group A ( control group ) : 300 IU r-FSH administer first 5 day stimulation cycle . Then first ultrasound scan perform monitor response . At stage dose rFSH adjust accord ovarian response continue day ovulatory hCG administration . Group B : rFSH supplement daily administration 100 IU hCG late follicular phase base follicle size ( 14mm ) . Group C : rFSH supplement daily administration 200 IU hCG late follicular phase base follicle size ( 14mm ) . To assess pregnancy outcome , serum hCG measure 2 week embryo transfer . Clinical pregnancy define observation sac fetal heart rate ultrasonography 4 week embryo transfer .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>1 . Poor ovarian response ovulation induction accord ESHRE definition [ 20 ] presence least 2 criterion need define poor responder include advanced maternal age , history low ovarian response previous IVF/ICSI treatment abnormal ovarian reserve test ( Antral Follicle number &lt; 5 ) 2. indication ICSI treatment , second third cycle 3 . Age 37 43 year 4 . Body mass index ( BMI ) ≤ 30 kg/m2 5 . The presence two functional ovary previous ovarian surgery 6 . The presence normal uterine cavity 2 normal tube base recent hysterosalpingographic hysteroscopic evaluation 7 . Basal ( day 2 3 ) serum FSH level ≤13 IU/L 8 . Normal semen analysis 9 . No history sign endometriosis 10 . No untreated endocrinologic disease</criteria>
	<gender>Female</gender>
	<minimum_age>37 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>ICSI Ovarian stimulation</keyword>
	<keyword>hCG low dose</keyword>
	<keyword>Oocyte maturity</keyword>
	<keyword>poor respond</keyword>
</DOC>